Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 and up

Comparing low and high Botox dilution for improving walking after stroke

Official title: Different Dilutions and Efficacy of Botulin Toxin in the Correction of the Hemiplegic Gait

Run by University of Ioannina · NCT04630873 · Data updated 2026-11-12

This study is testing whether using highly diluted Botox injections can help improve walking in people who have had a stroke better than using lower dilutions.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Ioannina
Academic / other
Locations1 site (Ioannina)
StatusRecruiting
StartedNovember 20, 2020
Main results expectedAugust 1, 2025
Study endsAugust 1, 2025
Registry record updatedDecember 6, 2024
Trial IDNCT04630873 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with equinovarus deformity and an average spasticity score of 3 on the Ashworth scale who can walk indoors with or without assistance.

Probably not a fit

Patients with mental illnesses that affect gait patterns or musculoskeletal diseases that interfere with walking may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of different dilutions of Botulin toxin type A (BTX-A) injections on gait improvement in patients with post-stroke spastic hemiplegia. It aims to determine whether highly diluted BTX-A injections provide a greater reduction in spasticity compared to lower dilutions. The study employs a crossover design, allowing participants to receive both treatment types, with gait analysis used to evaluate outcomes. This research addresses a significant gap in existing literature regarding optimal botulinum toxin dilution protocols.

Why it matters

Potential benefit: If successful, this study could lead to more effective treatment protocols for improving gait in stroke survivors with spastic hemiplegia.

How similar studies have gone: While there is ongoing debate regarding the efficacy of different BTX-A dilutions, this specific crossover study design has not been previously performed, making it a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* equinovarus deformity
* with an average 3 on Ashworth spasticity scale
* able to walk indoors either freely or with a cane.

Exclusion Criteria:

* patients suffering from any mental illness that would disturb the gait pattern
* patients suffering from musculoskeletal diseases that overtly interfere with the gait

Where it's running

  • Department of Physical Medicine and Rehabilitation, University Hospital of Ioannina
    Ioannina, Greece
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.